HOME_PAGE_HEADER_CONTENT
Learn More-HP Updated
Learn More
Featured News
Press Releases
November 08, 2024
NEW
ENHERTU® Receives Prestigious 2024 Prix Galien USA Award for Best Biotechnology Product
Download
October 30, 2024
NEW
Three Phase 3 Trials of Datopotamab Deruxtecan-Based Combinations Initiated in Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer
Download
October 01, 2024
ENHERTU® Granted Priority Review in the U.S. for Patients with HER2 Low or HER2 Ultralow Metastatic Breast Cancer Who Have Received at Least One Line of Endocrine Therapy
Download